Rank | Gene Set | Z-score |
---|---|---|
1 | desmosome organization (GO:0002934) | 7.79022032 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.94839488 |
3 | L-phenylalanine catabolic process (GO:0006559) | 6.94839488 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.80111857 |
5 | L-phenylalanine metabolic process (GO:0006558) | 6.80111857 |
6 | hemidesmosome assembly (GO:0031581) | 6.18183561 |
7 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.17644990 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.07754044 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.74468358 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.36617534 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.36617534 |
12 | tryptophan catabolic process (GO:0006569) | 5.36617534 |
13 | kynurenine metabolic process (GO:0070189) | 5.33042258 |
14 | sulfur amino acid catabolic process (GO:0000098) | 5.30090391 |
15 | urea cycle (GO:0000050) | 5.29414083 |
16 | urea metabolic process (GO:0019627) | 5.29414083 |
17 | cysteine metabolic process (GO:0006534) | 5.26511585 |
18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21410468 |
19 | bile acid biosynthetic process (GO:0006699) | 5.15940233 |
20 | negative regulation of fibrinolysis (GO:0051918) | 5.14087716 |
21 | tryptophan metabolic process (GO:0006568) | 5.12105705 |
22 | glyoxylate metabolic process (GO:0046487) | 5.07577832 |
23 | protein carboxylation (GO:0018214) | 4.94687215 |
24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.94687215 |
25 | alpha-linolenic acid metabolic process (GO:0036109) | 4.93762002 |
26 | regulation of fibrinolysis (GO:0051917) | 4.93677574 |
27 | proline biosynthetic process (GO:0006561) | 4.90610841 |
28 | regulation of protein activation cascade (GO:2000257) | 4.86837569 |
29 | complement activation, alternative pathway (GO:0006957) | 4.85816196 |
30 | nitrogen cycle metabolic process (GO:0071941) | 4.84184766 |
31 | serine family amino acid catabolic process (GO:0009071) | 4.79773593 |
32 | reverse cholesterol transport (GO:0043691) | 4.77446701 |
33 | homocysteine metabolic process (GO:0050667) | 4.71179989 |
34 | bile acid metabolic process (GO:0008206) | 4.63332841 |
35 | regulation of cholesterol esterification (GO:0010872) | 4.59769072 |
36 | regulation of complement activation (GO:0030449) | 4.54683770 |
37 | regulation of triglyceride catabolic process (GO:0010896) | 4.52470162 |
38 | aromatic amino acid family metabolic process (GO:0009072) | 4.49299802 |
39 | phospholipid efflux (GO:0033700) | 4.48906509 |
40 | acylglycerol homeostasis (GO:0055090) | 4.45995913 |
41 | triglyceride homeostasis (GO:0070328) | 4.45995913 |
42 | negative regulation of sterol transport (GO:0032372) | 4.44910236 |
43 | negative regulation of cholesterol transport (GO:0032375) | 4.44910236 |
44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44460675 |
45 | protein-lipid complex remodeling (GO:0034368) | 4.44460675 |
46 | macromolecular complex remodeling (GO:0034367) | 4.44460675 |
47 | bile acid and bile salt transport (GO:0015721) | 4.43156059 |
48 | regulation of water loss via skin (GO:0033561) | 4.41071428 |
49 | glycine metabolic process (GO:0006544) | 4.32083479 |
50 | amino-acid betaine metabolic process (GO:0006577) | 4.27812749 |
51 | proline metabolic process (GO:0006560) | 4.27400408 |
52 | tyrosine metabolic process (GO:0006570) | 4.20883095 |
53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.15732998 |
54 | lysine metabolic process (GO:0006553) | 4.14260424 |
55 | lysine catabolic process (GO:0006554) | 4.14260424 |
56 | alpha-amino acid catabolic process (GO:1901606) | 4.12037841 |
57 | regulation of cholesterol homeostasis (GO:2000188) | 4.08027362 |
58 | intestinal cholesterol absorption (GO:0030299) | 4.04188332 |
59 | COPI coating of Golgi vesicle (GO:0048205) | 4.04104088 |
60 | Golgi transport vesicle coating (GO:0048200) | 4.04104088 |
61 | imidazole-containing compound metabolic process (GO:0052803) | 4.03884282 |
62 | serine family amino acid metabolic process (GO:0009069) | 4.03365675 |
63 | activation of Rac GTPase activity (GO:0032863) | 3.99221749 |
64 | plasma lipoprotein particle clearance (GO:0034381) | 3.96859811 |
65 | epithelial cell-cell adhesion (GO:0090136) | 3.94418951 |
66 | cholesterol efflux (GO:0033344) | 3.92864769 |
67 | ethanol oxidation (GO:0006069) | 3.86665138 |
68 | cellular glucuronidation (GO:0052695) | 3.85038089 |
69 | plasma lipoprotein particle assembly (GO:0034377) | 3.84841036 |
70 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.83439210 |
71 | cellular amino acid catabolic process (GO:0009063) | 3.82524397 |
72 | drug catabolic process (GO:0042737) | 3.81009215 |
73 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.80303740 |
74 | indolalkylamine metabolic process (GO:0006586) | 3.80167753 |
75 | benzene-containing compound metabolic process (GO:0042537) | 3.80104169 |
76 | fibrinolysis (GO:0042730) | 3.79812006 |
77 | cellular modified amino acid catabolic process (GO:0042219) | 3.79644710 |
78 | response to nitrosative stress (GO:0051409) | 3.79549354 |
79 | gap junction assembly (GO:0016264) | 3.79068104 |
80 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.77721109 |
81 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77067191 |
82 | establishment of skin barrier (GO:0061436) | 3.75482778 |
83 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.74392581 |
84 | serine family amino acid biosynthetic process (GO:0009070) | 3.74197890 |
85 | glutamate metabolic process (GO:0006536) | 3.72425365 |
86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71451405 |
87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71451405 |
88 | multicellular organismal water homeostasis (GO:0050891) | 3.68069237 |
89 | cholesterol homeostasis (GO:0042632) | 3.67770056 |
90 | cellular ketone body metabolic process (GO:0046950) | 3.66255248 |
91 | lipoprotein metabolic process (GO:0042157) | 3.65885076 |
92 | amine catabolic process (GO:0009310) | 3.64720486 |
93 | cellular biogenic amine catabolic process (GO:0042402) | 3.64720486 |
94 | establishment of apical/basal cell polarity (GO:0035089) | 3.64100925 |
95 | sterol homeostasis (GO:0055092) | 3.62888188 |
96 | negative regulation of lipase activity (GO:0060192) | 3.60891608 |
97 | complement activation, classical pathway (GO:0006958) | 3.55518269 |
98 | phospholipid homeostasis (GO:0055091) | 3.54364643 |
99 | arginine metabolic process (GO:0006525) | 3.53255760 |
100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51564315 |
101 | aldehyde catabolic process (GO:0046185) | 3.51441194 |
102 | low-density lipoprotein particle remodeling (GO:0034374) | 3.47964844 |
103 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.47758070 |
104 | coenzyme catabolic process (GO:0009109) | 3.45523119 |
105 | ethanol metabolic process (GO:0006067) | 3.45047507 |
106 | complement activation (GO:0006956) | 3.44426598 |
107 | cell-substrate junction assembly (GO:0007044) | 3.44198848 |
108 | flavonoid metabolic process (GO:0009812) | 3.43561685 |
109 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.42686412 |
110 | uronic acid metabolic process (GO:0006063) | 3.41963299 |
111 | glucuronate metabolic process (GO:0019585) | 3.41963299 |
112 | protein retention in ER lumen (GO:0006621) | 3.41269607 |
113 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.41018372 |
114 | protein-lipid complex assembly (GO:0065005) | 3.40802799 |
115 | primary alcohol catabolic process (GO:0034310) | 3.39665178 |
116 | drug transmembrane transport (GO:0006855) | 3.39174718 |
117 | protein activation cascade (GO:0072376) | 3.38920288 |
118 | plasma lipoprotein particle organization (GO:0071827) | 3.38700541 |
119 | acute-phase response (GO:0006953) | 3.38601584 |
120 | intestinal absorption (GO:0050892) | 3.37683947 |
121 | carboxylic acid catabolic process (GO:0046395) | 3.34998141 |
122 | organic acid catabolic process (GO:0016054) | 3.34998141 |
123 | apoptotic process involved in morphogenesis (GO:0060561) | 3.34203359 |
124 | negative regulation of cell fate specification (GO:0009996) | 3.33572110 |
125 | blood coagulation, intrinsic pathway (GO:0007597) | 3.32031318 |
126 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.26501151 |
127 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.16616529 |
128 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.14195851 |
129 | GDP-mannose metabolic process (GO:0019673) | 3.11318183 |
130 | glucose 6-phosphate metabolic process (GO:0051156) | 3.10866040 |
131 | protein autoprocessing (GO:0016540) | 3.10801275 |
132 | NADH metabolic process (GO:0006734) | 3.08306496 |
133 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.05845873 |
134 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.03713962 |
135 | regulation of cholesterol metabolic process (GO:0090181) | 3.02951615 |
136 | atrioventricular valve morphogenesis (GO:0003181) | 3.01003987 |
137 | tight junction assembly (GO:0070830) | 3.00046533 |
138 | adherens junction assembly (GO:0034333) | 2.99073660 |
139 | cell-substrate adherens junction assembly (GO:0007045) | 2.96288602 |
140 | focal adhesion assembly (GO:0048041) | 2.96288602 |
141 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.87521169 |
142 | water homeostasis (GO:0030104) | 2.87310314 |
143 | semaphorin-plexin signaling pathway (GO:0071526) | 2.85979789 |
144 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.85097718 |
145 | regulation of cardioblast differentiation (GO:0051890) | 2.84098155 |
146 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.83069228 |
147 | maternal placenta development (GO:0001893) | 2.82509717 |
148 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.81356831 |
149 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.81180697 |
150 | intestinal epithelial cell development (GO:0060576) | 2.79816603 |
151 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.78920967 |
152 | negative regulation of viral release from host cell (GO:1902187) | 2.71958241 |
153 | heterochromatin organization (GO:0070828) | 2.68537295 |
154 | glucose catabolic process (GO:0006007) | 2.68326445 |
155 | trophectodermal cell differentiation (GO:0001829) | 2.67606019 |
156 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.66861569 |
157 | amyloid precursor protein catabolic process (GO:0042987) | 2.63399647 |
158 | surfactant homeostasis (GO:0043129) | 2.63308024 |
159 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.62037503 |
160 | establishment of monopolar cell polarity (GO:0061162) | 2.62037503 |
161 | regulation of viral release from host cell (GO:1902186) | 2.58814909 |
162 | regulation of translational fidelity (GO:0006450) | 2.58087486 |
163 | positive regulation of epidermis development (GO:0045684) | 2.57087471 |
164 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.56973183 |
165 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.56586114 |
166 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.56149316 |
167 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.55573869 |
168 | amyloid precursor protein metabolic process (GO:0042982) | 2.54291244 |
169 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.53911807 |
170 | L-serine metabolic process (GO:0006563) | 2.51433476 |
171 | keratinocyte proliferation (GO:0043616) | 2.50700618 |
172 | cell-cell junction assembly (GO:0007043) | 2.48206580 |
173 | convergent extension (GO:0060026) | 2.48054596 |
174 | 4-hydroxyproline metabolic process (GO:0019471) | 2.46592723 |
175 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.46505992 |
176 | lung epithelium development (GO:0060428) | 2.44981420 |
177 | protein complex localization (GO:0031503) | 2.44726630 |
178 | receptor catabolic process (GO:0032801) | 2.43265037 |
179 | ear development (GO:0043583) | 2.42802462 |
180 | response to food (GO:0032094) | 2.41831773 |
181 | negative regulation of cell size (GO:0045792) | 2.40466948 |
182 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.40068844 |
183 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.40068844 |
184 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.39927590 |
185 | basement membrane organization (GO:0071711) | 2.39778180 |
186 | cell-cell junction maintenance (GO:0045217) | 2.38231825 |
187 | epoxygenase P450 pathway (GO:0019373) | 2.38023668 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.24245586 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.53008206 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.72302535 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63885686 |
5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.55066894 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.46558067 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.30676823 |
8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.98112610 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.45832651 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.38883034 |
11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.43604453 |
12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.31800834 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.13761284 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2680395 |
15 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.96524820 |
16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89347769 |
17 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.89304553 |
18 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.87934080 |
19 | MYC_22102868_ChIP-Seq_BL_Human | 1.84232129 |
20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82593700 |
21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.78328189 |
22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.77947782 |
23 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.74146870 |
24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70262728 |
25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61759682 |
26 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.61535373 |
27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60398891 |
28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.57449138 |
29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55097320 |
30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53635439 |
31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52948835 |
32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.47955518 |
33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.47599972 |
34 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46217637 |
35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.45163926 |
36 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.44585197 |
37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.44419804 |
38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41870197 |
39 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41760928 |
40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41327092 |
41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41030376 |
42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40447818 |
43 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40425292 |
44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38947505 |
45 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37693265 |
46 | P68_20966046_ChIP-Seq_HELA_Human | 1.37163534 |
47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36870277 |
48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.36088412 |
49 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35738626 |
50 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.34276900 |
51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.27066482 |
52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25156429 |
53 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.24613401 |
54 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20325769 |
55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.19532922 |
56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19305543 |
57 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17732138 |
58 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.15518545 |
59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14298768 |
60 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13947344 |
61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.13648274 |
62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12900812 |
63 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12456236 |
64 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10351851 |
65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10279681 |
66 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09980195 |
67 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09559067 |
68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09027111 |
69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.07695392 |
70 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06000187 |
71 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05890028 |
72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04943558 |
73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04598266 |
74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04221567 |
75 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.03501221 |
76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02993569 |
77 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01582960 |
78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01534908 |
79 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.01291209 |
80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00836132 |
81 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.00240615 |
82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.99683642 |
83 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.99484375 |
84 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98252959 |
85 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.98080952 |
86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97597271 |
87 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.97308527 |
88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96934644 |
89 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96604465 |
90 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94865307 |
91 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91471606 |
92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90247943 |
93 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89043755 |
94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87717063 |
95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87418626 |
96 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86534425 |
97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86429921 |
98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85829850 |
99 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.84959078 |
100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84899477 |
101 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.84399355 |
102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83347760 |
103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82569593 |
104 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81451645 |
105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80603638 |
106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80150439 |
107 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.80113414 |
108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79215527 |
109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78107373 |
110 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.77985255 |
111 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.77717458 |
112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76209499 |
113 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73060196 |
114 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.72570779 |
115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71985077 |
116 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70350782 |
117 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70212715 |
118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69934418 |
119 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.69559573 |
120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69464077 |
121 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.69283103 |
122 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.65366099 |
123 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64318841 |
124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63799132 |
125 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.63735251 |
126 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.63356531 |
127 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63346741 |
128 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62874617 |
129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62745893 |
130 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61641549 |
131 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.61495946 |
132 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.61192299 |
133 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.60088921 |
134 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.58542864 |
135 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.58542864 |
136 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.58251730 |
137 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.58220677 |
138 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.58213359 |
139 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.57303275 |
140 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.54628797 |
141 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53916079 |
142 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53549072 |
143 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.53517256 |
144 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.52854853 |
145 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.52073278 |
146 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.51859656 |
147 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.51502838 |
148 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.51015759 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.28640410 |
2 | MP0005360_urolithiasis | 6.73633459 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.71739526 |
4 | MP0005365_abnormal_bile_salt | 5.50988463 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.47675462 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.72728011 |
7 | MP0003252_abnormal_bile_duct | 3.56009359 |
8 | MP0009840_abnormal_foam_cell | 3.23203840 |
9 | MP0010329_abnormal_lipoprotein_level | 3.17927760 |
10 | MP0001666_abnormal_nutrient_absorption | 3.10992789 |
11 | MP0005083_abnormal_biliary_tract | 2.85426920 |
12 | MP0003195_calcinosis | 2.75597081 |
13 | MP0005332_abnormal_amino_acid | 2.42599751 |
14 | MP0010234_abnormal_vibrissa_follicle | 2.41832401 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.40202715 |
16 | MP0003941_abnormal_skin_development | 2.32245016 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.29980853 |
18 | MP0005076_abnormal_cell_differentiation | 2.27733100 |
19 | MP0000678_abnormal_parathyroid_gland | 2.25987558 |
20 | MP0002138_abnormal_hepatobiliary_system | 2.19438982 |
21 | MP0003566_abnormal_cell_adhesion | 2.06169408 |
22 | MP0000609_abnormal_liver_physiology | 1.96219845 |
23 | MP0003693_abnormal_embryo_hatching | 1.79369425 |
24 | MP0002118_abnormal_lipid_homeostasis | 1.78407886 |
25 | MP0003868_abnormal_feces_composition | 1.77163666 |
26 | MP0002254_reproductive_system_inflammat | 1.75423937 |
27 | MP0000762_abnormal_tongue_morphology | 1.67365714 |
28 | MP0004264_abnormal_extraembryonic_tissu | 1.64334805 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.61197089 |
30 | MP0004185_abnormal_adipocyte_glucose | 1.60413430 |
31 | MP0005409_darkened_coat_color | 1.60239175 |
32 | MP0005319_abnormal_enzyme/_coenzyme | 1.58134356 |
33 | MP0002796_impaired_skin_barrier | 1.52471634 |
34 | MP0002249_abnormal_larynx_morphology | 1.52283181 |
35 | MP0004858_abnormal_nervous_system | 1.49587615 |
36 | MP0010030_abnormal_orbit_morphology | 1.47226827 |
37 | MP0009643_abnormal_urine_homeostasis | 1.46178787 |
38 | MP0000383_abnormal_hair_follicle | 1.45878265 |
39 | MP0002089_abnormal_postnatal_growth/wei | 1.45226142 |
40 | MP0004957_abnormal_blastocyst_morpholog | 1.42272831 |
41 | MP0004272_abnormal_basement_membrane | 1.38366208 |
42 | MP0001764_abnormal_homeostasis | 1.37526068 |
43 | MP0003123_paternal_imprinting | 1.33366062 |
44 | MP0010771_integument_phenotype | 1.25726290 |
45 | MP0003011_delayed_dark_adaptation | 1.23203641 |
46 | MP0005451_abnormal_body_composition | 1.20569599 |
47 | MP0001730_embryonic_growth_arrest | 1.19936293 |
48 | MP0005220_abnormal_exocrine_pancreas | 1.18130186 |
49 | MP0003315_abnormal_perineum_morphology | 1.17361525 |
50 | MP0000627_abnormal_mammary_gland | 1.16619324 |
51 | MP0009053_abnormal_anal_canal | 1.14755359 |
52 | MP0000490_abnormal_crypts_of | 1.13270712 |
53 | MP0003186_abnormal_redox_activity | 1.12782232 |
54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09706810 |
55 | MP0005257_abnormal_intraocular_pressure | 1.09243141 |
56 | MP0005058_abnormal_lysosome_morphology | 1.07614658 |
57 | * MP0000598_abnormal_liver_morphology | 1.05926443 |
58 | MP0002098_abnormal_vibrissa_morphology | 1.02438762 |
59 | MP0005408_hypopigmentation | 1.01901506 |
60 | * MP0009931_abnormal_skin_appearance | 1.01562207 |
61 | MP0000858_altered_metastatic_potential | 1.01277575 |
62 | MP0003878_abnormal_ear_physiology | 1.00688979 |
63 | MP0005377_hearing/vestibular/ear_phenot | 1.00688979 |
64 | MP0005084_abnormal_gallbladder_morpholo | 1.00453273 |
65 | MP0005636_abnormal_mineral_homeostasis | 0.98043754 |
66 | MP0005647_abnormal_sex_gland | 0.94260662 |
67 | MP0008260_abnormal_autophagy | 0.92760259 |
68 | MP0009697_abnormal_copulation | 0.91493064 |
69 | MP0003453_abnormal_keratinocyte_physiol | 0.90181172 |
70 | MP0001756_abnormal_urination | 0.87085860 |
71 | MP0002086_abnormal_extraembryonic_tissu | 0.86637502 |
72 | MP0005501_abnormal_skin_physiology | 0.84215865 |
73 | MP0002697_abnormal_eye_size | 0.83045798 |
74 | MP0004381_abnormal_hair_follicle | 0.82403704 |
75 | MP0002060_abnormal_skin_morphology | 0.81702305 |
76 | MP0002111_abnormal_tail_morphology | 0.81602387 |
77 | MP0009642_abnormal_blood_homeostasis | 0.77441418 |
78 | MP0009780_abnormal_chondrocyte_physiolo | 0.77348544 |
79 | MP0000579_abnormal_nail_morphology | 0.76479968 |
80 | MP0001672_abnormal_embryogenesis/_devel | 0.75984098 |
81 | MP0005380_embryogenesis_phenotype | 0.75984098 |
82 | MP0008932_abnormal_embryonic_tissue | 0.75945408 |
83 | MP0001664_abnormal_digestion | 0.75601768 |
84 | MP0009763_increased_sensitivity_to | 0.75588652 |
85 | MP0005375_adipose_tissue_phenotype | 0.74803282 |
86 | MP0000003_abnormal_adipose_tissue | 0.74791279 |
87 | MP0010678_abnormal_skin_adnexa | 0.74563364 |
88 | MP0003111_abnormal_nucleus_morphology | 0.74030835 |
89 | MP0000470_abnormal_stomach_morphology | 0.73795145 |
90 | MP0003984_embryonic_growth_retardation | 0.73537288 |
91 | MP0002080_prenatal_lethality | 0.73104143 |
92 | MP0000537_abnormal_urethra_morphology | 0.72895629 |
93 | MP0002078_abnormal_glucose_homeostasis | 0.71449547 |
94 | MP0001216_abnormal_epidermal_layer | 0.70984899 |
95 | MP0003300_gastrointestinal_ulcer | 0.70984874 |
96 | MP0002085_abnormal_embryonic_tissue | 0.70658620 |
97 | MP0004782_abnormal_surfactant_physiolog | 0.70612838 |
98 | MP0010368_abnormal_lymphatic_system | 0.70370099 |
99 | MP0001346_abnormal_lacrimal_gland | 0.69863533 |
100 | MP0003115_abnormal_respiratory_system | 0.69162884 |
101 | MP0002088_abnormal_embryonic_growth/wei | 0.68872238 |
102 | MP0008469_abnormal_protein_level | 0.68193211 |
103 | MP0009764_decreased_sensitivity_to | 0.67438711 |
104 | MP0000350_abnormal_cell_proliferation | 0.65898842 |
105 | MP0002877_abnormal_melanocyte_morpholog | 0.64926618 |
106 | MP0000367_abnormal_coat/_hair | 0.64727742 |
107 | MP0001765_abnormal_ion_homeostasis | 0.64541599 |
108 | MP0000462_abnormal_digestive_system | 0.64311402 |
109 | MP0009384_cardiac_valve_regurgitation | 0.64276268 |
110 | MP0002136_abnormal_kidney_physiology | 0.63047885 |
111 | MP0005248_abnormal_Harderian_gland | 0.62840432 |
112 | MP0003183_abnormal_peptide_metabolism | 0.62619832 |
113 | MP0003718_maternal_effect | 0.62458563 |
114 | MP0000604_amyloidosis | 0.62172551 |
115 | MP0009379_abnormal_foot_pigmentation | 0.61490826 |
116 | MP0009765_abnormal_xenobiotic_induced | 0.61256704 |
117 | MP0001661_extended_life_span | 0.61171666 |
118 | MP0002084_abnormal_developmental_patter | 0.61122674 |
119 | MP0001944_abnormal_pancreas_morphology | 0.60167371 |
120 | MP0005376_homeostasis/metabolism_phenot | 0.58976632 |
121 | MP0003119_abnormal_digestive_system | 0.58243237 |
122 | MP0005670_abnormal_white_adipose | 0.57955847 |
123 | MP0000377_abnormal_hair_follicle | 0.57376642 |
124 | MP0000566_synostosis | 0.56331812 |
125 | MP0002928_abnormal_bile_duct | 0.55954952 |
126 | MP0000427_abnormal_hair_cycle | 0.55907469 |
127 | MP0005395_other_phenotype | 0.55792039 |
128 | MP0000467_abnormal_esophagus_morphology | 0.55140869 |
129 | MP0000538_abnormal_urinary_bladder | 0.54202768 |
130 | MP0003638_abnormal_response/metabolism_ | 0.53557852 |
131 | MP0005334_abnormal_fat_pad | 0.53266823 |
132 | MP0004947_skin_inflammation | 0.52708187 |
133 | MP0009672_abnormal_birth_weight | 0.52599461 |
134 | MP0010352_gastrointestinal_tract_polyps | 0.52282568 |
135 | MP0003656_abnormal_erythrocyte_physiolo | 0.52085551 |
136 | MP0003890_abnormal_embryonic-extraembry | 0.50646904 |
137 | MP0005023_abnormal_wound_healing | 0.49210284 |
138 | MP0002971_abnormal_brown_adipose | 0.48066023 |
139 | MP0005266_abnormal_metabolism | 0.47397868 |
140 | MP0000477_abnormal_intestine_morphology | 0.45822663 |
141 | MP0002876_abnormal_thyroid_physiology | 0.45360840 |
142 | MP0005448_abnormal_energy_balance | 0.44379608 |
143 | MP0000613_abnormal_salivary_gland | 0.43682650 |
144 | MP0006036_abnormal_mitochondrial_physio | 0.43679899 |
145 | MP0001881_abnormal_mammary_gland | 0.43618648 |
146 | MP0005666_abnormal_adipose_tissue | 0.43035035 |
147 | MP0003953_abnormal_hormone_level | 0.42378129 |
148 | MP0005275_abnormal_skin_tensile | 0.42272543 |
149 | MP0004043_abnormal_pH_regulation | 0.42174926 |
150 | MP0000639_abnormal_adrenal_gland | 0.42171133 |
151 | MP0001873_stomach_inflammation | 0.41980246 |
152 | MP0001849_ear_inflammation | 0.41343363 |
153 | MP0008004_abnormal_stomach_pH | 0.40879460 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.02837247 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.01002886 |
3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.69123589 |
4 | Deep venous thrombosis (HP:0002625) | 6.56681049 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.15383569 |
6 | Xanthomatosis (HP:0000991) | 5.82588855 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.65184601 |
8 | Pili torti (HP:0003777) | 4.93038993 |
9 | Complement deficiency (HP:0004431) | 4.78149964 |
10 | Hyperlipoproteinemia (HP:0010980) | 4.76988087 |
11 | Hypoglycemic coma (HP:0001325) | 4.54870870 |
12 | Hypolipoproteinemia (HP:0010981) | 4.54316786 |
13 | Hyperammonemia (HP:0001987) | 4.28222630 |
14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.23242059 |
15 | Fat malabsorption (HP:0002630) | 4.17839084 |
16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.10559527 |
17 | Ketosis (HP:0001946) | 4.08931284 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.06413478 |
19 | Fragile nails (HP:0001808) | 4.04554204 |
20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.03087882 |
21 | Epidermoid cyst (HP:0200040) | 4.01088503 |
22 | Joint hemorrhage (HP:0005261) | 3.88117994 |
23 | Hyperglycinemia (HP:0002154) | 3.87893796 |
24 | Hypoalphalipoproteinemia (HP:0003233) | 3.80084475 |
25 | Abnormal hair laboratory examination (HP:0003328) | 3.79554380 |
26 | Hyperglycinuria (HP:0003108) | 3.78268782 |
27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.78003763 |
28 | Milia (HP:0001056) | 3.75905369 |
29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.68625700 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.65406335 |
31 | Abnormality of methionine metabolism (HP:0010901) | 3.64963099 |
32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.64774889 |
33 | Abnormality of complement system (HP:0005339) | 3.62056731 |
34 | Abnormality of glycine metabolism (HP:0010895) | 3.52918186 |
35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.52918186 |
36 | Flat acetabular roof (HP:0003180) | 3.39663671 |
37 | Hypercholesterolemia (HP:0003124) | 3.38706998 |
38 | Ketoacidosis (HP:0001993) | 3.30637852 |
39 | Hypoglycemic seizures (HP:0002173) | 3.28737407 |
40 | Plantar hyperkeratosis (HP:0007556) | 3.25032417 |
41 | Onycholysis (HP:0001806) | 3.24241188 |
42 | Late onset (HP:0003584) | 3.21916353 |
43 | Pterygium (HP:0001059) | 3.20291756 |
44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11068078 |
45 | Selective tooth agenesis (HP:0001592) | 3.07141698 |
46 | Steatorrhea (HP:0002570) | 3.01309614 |
47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.00643958 |
48 | Hyperbilirubinemia (HP:0002904) | 2.99846923 |
49 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.98559954 |
50 | Abnormality of nail color (HP:0100643) | 2.95764449 |
51 | Gout (HP:0001997) | 2.93861467 |
52 | Esophageal varix (HP:0002040) | 2.92946546 |
53 | Septate vagina (HP:0001153) | 2.91379047 |
54 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.89869690 |
55 | Hepatocellular carcinoma (HP:0001402) | 2.87497929 |
56 | Malnutrition (HP:0004395) | 2.84443239 |
57 | Abnormality of purine metabolism (HP:0004352) | 2.84214673 |
58 | Delayed CNS myelination (HP:0002188) | 2.73678648 |
59 | Vascular calcification (HP:0004934) | 2.73162825 |
60 | Ridged nail (HP:0001807) | 2.71039337 |
61 | Right ventricular cardiomyopathy (HP:0011663) | 2.62251712 |
62 | Bronchomalacia (HP:0002780) | 2.60036449 |
63 | Alopecia of scalp (HP:0002293) | 2.59269831 |
64 | Advanced eruption of teeth (HP:0006288) | 2.59139839 |
65 | Spontaneous abortion (HP:0005268) | 2.51758597 |
66 | Myocardial infarction (HP:0001658) | 2.50424566 |
67 | Hyperglycemia (HP:0003074) | 2.49541707 |
68 | Abnormality of serum amino acid levels (HP:0003112) | 2.48879827 |
69 | Metabolic acidosis (HP:0001942) | 2.47652759 |
70 | Spastic diplegia (HP:0001264) | 2.47274334 |
71 | Lethargy (HP:0001254) | 2.46458553 |
72 | Symptomatic seizures (HP:0011145) | 2.46062540 |
73 | Nail dystrophy (HP:0008404) | 2.45211051 |
74 | Skin nodule (HP:0200036) | 2.45196670 |
75 | Atrophic scars (HP:0001075) | 2.42355696 |
76 | Hyperactive renin-angiotensin system (HP:0000841) | 2.40345186 |
77 | Dicarboxylic aciduria (HP:0003215) | 2.39427713 |
78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39427713 |
79 | Hyperacusis (HP:0010780) | 2.38359031 |
80 | Abnormality of the gastric mucosa (HP:0004295) | 2.38009060 |
81 | Broad face (HP:0000283) | 2.37914711 |
82 | Cardiovascular calcification (HP:0011915) | 2.37454843 |
83 | Abnormality of the salivary glands (HP:0010286) | 2.34997963 |
84 | Systemic lupus erythematosus (HP:0002725) | 2.34261744 |
85 | Irritability (HP:0000737) | 2.33916964 |
86 | Hypoplasia of dental enamel (HP:0006297) | 2.33305010 |
87 | Focal segmental glomerulosclerosis (HP:0000097) | 2.33251962 |
88 | Trismus (HP:0000211) | 2.31759461 |
89 | Acanthocytosis (HP:0001927) | 2.31525533 |
90 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.29770666 |
91 | Sparse eyelashes (HP:0000653) | 2.29615300 |
92 | Amelogenesis imperfecta (HP:0000705) | 2.28724702 |
93 | Hypotrichosis (HP:0001006) | 2.26289330 |
94 | Cholecystitis (HP:0001082) | 2.25177575 |
95 | Abnormal gallbladder physiology (HP:0012438) | 2.25177575 |
96 | Abnormal gallbladder morphology (HP:0012437) | 2.21482653 |
97 | Glomerulonephritis (HP:0000099) | 2.19885472 |
98 | Micronodular cirrhosis (HP:0001413) | 2.14854614 |
99 | Abnormal blistering of the skin (HP:0008066) | 2.14533905 |
100 | Generalized aminoaciduria (HP:0002909) | 2.14006286 |
101 | Deviation of the thumb (HP:0009603) | 2.11927420 |
102 | Ulnar bowing (HP:0003031) | 2.11831054 |
103 | Hydroxyprolinuria (HP:0003080) | 2.11716135 |
104 | Abnormality of proline metabolism (HP:0010907) | 2.11716135 |
105 | Woolly hair (HP:0002224) | 2.11669023 |
106 | Hypochromic microcytic anemia (HP:0004840) | 2.10697475 |
107 | Pancreatitis (HP:0001733) | 2.10307331 |
108 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.09238581 |
109 | Abnormality of vitamin metabolism (HP:0100508) | 2.08712802 |
110 | Abnormal tarsal ossification (HP:0008369) | 2.08588171 |
111 | Rickets (HP:0002748) | 2.08404253 |
112 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.07516043 |
113 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.07516043 |
114 | Glomerulosclerosis (HP:0000096) | 2.06604752 |
115 | Abnormality of the Achilles tendon (HP:0005109) | 2.06516598 |
116 | Neonatal onset (HP:0003623) | 2.05493246 |
117 | Cholelithiasis (HP:0001081) | 2.05459659 |
118 | Distal lower limb muscle weakness (HP:0009053) | 2.04736518 |
119 | Acanthosis nigricans (HP:0000956) | 2.02320587 |
120 | Palmoplantar hyperkeratosis (HP:0000972) | 2.01751923 |
121 | Amyloidosis (HP:0011034) | 2.01654601 |
122 | Abnormality of carpal bone ossification (HP:0006257) | 2.01137890 |
123 | Stridor (HP:0010307) | 1.99875168 |
124 | Brushfield spots (HP:0001088) | 1.99455937 |
125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99260249 |
126 | Diaphragmatic weakness (HP:0009113) | 1.99183268 |
127 | Distal upper limb amyotrophy (HP:0007149) | 1.99087838 |
128 | Upper limb amyotrophy (HP:0009129) | 1.99087838 |
129 | Bifid scrotum (HP:0000048) | 1.98215016 |
130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96970979 |
131 | Thick nail (HP:0001805) | 1.96039354 |
132 | Proximal tubulopathy (HP:0000114) | 1.95825721 |
133 | Ankyloglossia (HP:0010296) | 1.94990442 |
134 | Abnormal cartilage morphology (HP:0002763) | 1.94984871 |
135 | Asymmetry of the thorax (HP:0001555) | 1.94683219 |
136 | Lip pit (HP:0100267) | 1.93469304 |
137 | Curly hair (HP:0002212) | 1.92581725 |
138 | Abnormality of urine glucose concentration (HP:0011016) | 1.91950450 |
139 | Glycosuria (HP:0003076) | 1.91950450 |
140 | Enlarged kidneys (HP:0000105) | 1.91732479 |
141 | Thin bony cortex (HP:0002753) | 1.91086752 |
142 | Increased purine levels (HP:0004368) | 1.90947926 |
143 | Hyperuricemia (HP:0002149) | 1.90947926 |
144 | Hyperparathyroidism (HP:0000843) | 1.90842436 |
145 | Abdominal distention (HP:0003270) | 1.90742192 |
146 | Proximal placement of thumb (HP:0009623) | 1.89953686 |
147 | Back pain (HP:0003418) | 1.88868545 |
148 | Germ cell neoplasia (HP:0100728) | 1.88086541 |
149 | Hemorrhage of the eye (HP:0011885) | 1.86661621 |
150 | Achilles tendon contracture (HP:0001771) | 1.86167807 |
151 | Abnormality of the gallbladder (HP:0005264) | 1.86134184 |
152 | Distal lower limb amyotrophy (HP:0008944) | 1.85779801 |
153 | Long palpebral fissure (HP:0000637) | 1.85022462 |
154 | J-shaped sella turcica (HP:0002680) | 1.84418906 |
155 | Cerebral edema (HP:0002181) | 1.84155743 |
156 | Menorrhagia (HP:0000132) | 1.84000936 |
157 | Sensorimotor neuropathy (HP:0007141) | 1.83038568 |
158 | Flattened epiphyses (HP:0003071) | 1.82964224 |
159 | Mitral stenosis (HP:0001718) | 1.82758966 |
160 | Nasolacrimal duct obstruction (HP:0000579) | 1.82642503 |
161 | Fragile skin (HP:0001030) | 1.82526102 |
162 | Abnormality of the lacrimal duct (HP:0011481) | 1.82200729 |
163 | Vomiting (HP:0002013) | 1.80491269 |
164 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79558488 |
165 | Natal tooth (HP:0000695) | 1.79454356 |
166 | Palmar hyperkeratosis (HP:0010765) | 1.79341351 |
167 | Progressive hearing impairment (HP:0001730) | 1.78816967 |
168 | Abnormality of the dental root (HP:0006486) | 1.77985204 |
169 | Taurodontia (HP:0000679) | 1.77985204 |
170 | Abnormality of permanent molar morphology (HP:0011071) | 1.77985204 |
171 | Seborrheic dermatitis (HP:0001051) | 1.77200353 |
172 | Abnormal ossification of hand bones (HP:0005921) | 1.73288305 |
173 | Progressive sensorineural hearing impairment (HP:0000408) | 1.72847489 |
174 | Popliteal pterygium (HP:0009756) | 1.70227630 |
175 | Ureteral stenosis (HP:0000071) | 1.69605358 |
176 | Abnormal vertebral ossification (HP:0100569) | 1.68583018 |
177 | Ventricular tachycardia (HP:0004756) | 1.66488960 |
178 | Spinal cord compression (HP:0002176) | 1.63027491 |
179 | Absent eyelashes (HP:0000561) | 1.62895193 |
180 | Anonychia (HP:0001798) | 1.62452597 |
181 | Abnormality of oral frenula (HP:0000190) | 1.62071017 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.84681449 |
2 | EPHA2 | 4.45200554 |
3 | ERN1 | 4.34435811 |
4 | SMG1 | 3.88623231 |
5 | FGFR4 | 3.21161053 |
6 | SIK1 | 3.05059356 |
7 | MST1R | 2.97691098 |
8 | LATS1 | 2.54864932 |
9 | PTK6 | 2.51635617 |
10 | TAOK3 | 2.46499491 |
11 | MAPK15 | 2.45082104 |
12 | FRK | 2.44551496 |
13 | INSRR | 2.38678725 |
14 | ERBB4 | 2.27359392 |
15 | MAP3K3 | 2.21177658 |
16 | NME2 | 2.09633663 |
17 | MAP2K2 | 2.08155372 |
18 | EEF2K | 2.06617047 |
19 | TRIB3 | 1.82896240 |
20 | PIK3CG | 1.59331151 |
21 | PKN2 | 1.59184507 |
22 | MET | 1.57148918 |
23 | MAP3K2 | 1.52643341 |
24 | STK38L | 1.50195719 |
25 | PTK2 | 1.48072158 |
26 | FLT3 | 1.43703133 |
27 | MAP3K10 | 1.30012104 |
28 | FER | 1.29620759 |
29 | MAPK11 | 1.26682231 |
30 | RPS6KB2 | 1.26058762 |
31 | KDR | 1.25426560 |
32 | MAP3K11 | 1.25190274 |
33 | DYRK1B | 1.20499123 |
34 | NME1 | 1.15537808 |
35 | RIPK1 | 1.15313936 |
36 | EPHB2 | 1.14468696 |
37 | MAP3K9 | 1.12405083 |
38 | WNK3 | 1.12269187 |
39 | VRK2 | 1.10532922 |
40 | ERBB2 | 1.08110490 |
41 | NEK9 | 1.05728970 |
42 | ARAF | 1.03108694 |
43 | MAP2K3 | 1.03096134 |
44 | TYK2 | 1.01942345 |
45 | BMX | 1.01790429 |
46 | CDK6 | 0.98722958 |
47 | IRAK3 | 0.96344200 |
48 | MAPKAPK3 | 0.91307234 |
49 | PRPF4B | 0.91179340 |
50 | MAP2K6 | 0.87430216 |
51 | PAK4 | 0.85730796 |
52 | MAP2K1 | 0.84562982 |
53 | MST4 | 0.84066522 |
54 | TESK2 | 0.81655210 |
55 | PASK | 0.78091666 |
56 | STK24 | 0.74613317 |
57 | ABL2 | 0.73983052 |
58 | EPHB1 | 0.71879692 |
59 | MAP3K1 | 0.70863990 |
60 | LRRK2 | 0.70623211 |
61 | JAK2 | 0.70277342 |
62 | MTOR | 0.69667114 |
63 | DAPK2 | 0.67990662 |
64 | ICK | 0.67362136 |
65 | SCYL2 | 0.67342245 |
66 | GSK3A | 0.64544469 |
67 | LATS2 | 0.64451661 |
68 | GRK1 | 0.63037654 |
69 | PRKAA2 | 0.62715921 |
70 | GRK6 | 0.62062827 |
71 | TBK1 | 0.60854224 |
72 | NUAK1 | 0.59944792 |
73 | PRKCI | 0.59941327 |
74 | RPS6KA2 | 0.59590375 |
75 | MAP3K8 | 0.59206363 |
76 | STK10 | 0.58922180 |
77 | EPHA3 | 0.58856178 |
78 | MUSK | 0.55997199 |
79 | TESK1 | 0.54285428 |
80 | AKT3 | 0.53868128 |
81 | ILK | 0.53787133 |
82 | SIK3 | 0.52748874 |
83 | MAP2K4 | 0.52313649 |
84 | BUB1 | 0.52118272 |
85 | IRAK2 | 0.52099701 |
86 | CHUK | 0.51792546 |
87 | MAP3K7 | 0.51428172 |
88 | CDK4 | 0.51346984 |
89 | CDK12 | 0.50672437 |
90 | CDC42BPA | 0.50330120 |
91 | PRKG2 | 0.49857225 |
92 | NTRK1 | 0.49446028 |
93 | PDPK1 | 0.49381822 |
94 | CDK9 | 0.48992849 |
95 | PRKD2 | 0.48021112 |
96 | BRAF | 0.47622652 |
97 | CAMK2G | 0.47425916 |
98 | PIM2 | 0.47341215 |
99 | TIE1 | 0.45969004 |
100 | WNK4 | 0.44742581 |
101 | NLK | 0.43745547 |
102 | FGFR2 | 0.43627862 |
103 | CSK | 0.43484711 |
104 | STK39 | 0.42489905 |
105 | LMTK2 | 0.42449202 |
106 | TAOK2 | 0.41859270 |
107 | RPS6KA4 | 0.41702756 |
108 | PRKD3 | 0.41636302 |
109 | PDGFRA | 0.40433332 |
110 | TTN | 0.39761401 |
111 | TGFBR2 | 0.39741200 |
112 | FGFR1 | 0.39650400 |
113 | STK3 | 0.38858138 |
114 | RPS6KC1 | 0.38300088 |
115 | RPS6KL1 | 0.38300088 |
116 | AKT2 | 0.38237868 |
117 | NEK6 | 0.38093103 |
118 | EIF2AK1 | 0.37252912 |
119 | MAP3K12 | 0.36402660 |
120 | TAF1 | 0.36400678 |
121 | PRKCZ | 0.35946621 |
122 | MAPKAPK2 | 0.35813748 |
123 | TSSK6 | 0.35709953 |
124 | PBK | 0.34278234 |
125 | HIPK2 | 0.34251956 |
126 | DAPK1 | 0.33958423 |
127 | TGFBR1 | 0.32234976 |
128 | TAOK1 | 0.31449949 |
129 | MELK | 0.31052984 |
130 | PRKACG | 0.30945652 |
131 | CAMK1D | 0.29703791 |
132 | PIK3CA | 0.29479386 |
133 | KSR2 | 0.28403411 |
134 | CSNK1E | 0.27709246 |
135 | FGFR3 | 0.27503635 |
136 | CDK8 | 0.27424850 |
137 | RET | 0.27030783 |
138 | PRKAA1 | 0.26613406 |
139 | MAP3K5 | 0.26097068 |
140 | ACVR1B | 0.26002832 |
141 | CDK7 | 0.26002501 |
142 | AURKB | 0.24681506 |
143 | RPS6KA1 | 0.24539217 |
144 | EGFR | 0.24363034 |
145 | TTK | 0.22521034 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.05547323 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.46085332 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43081395 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.94588397 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84974913 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63861622 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56714981 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43949518 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42959372 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41404535 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27637280 |
12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.27274717 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23593312 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.22462441 |
15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.21123521 |
16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12240454 |
17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.04136672 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99856877 |
19 | Peroxisome_Homo sapiens_hsa04146 | 1.87779281 |
20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.85185705 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80632900 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80256719 |
23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.79799239 |
24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79480046 |
25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.78252155 |
26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76954417 |
27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75879841 |
28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73088455 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65485494 |
30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.65368858 |
31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63496849 |
32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62578262 |
33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62260106 |
34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58090062 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.50680716 |
36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48577048 |
37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.47416824 |
38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46010274 |
39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41883147 |
40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40079294 |
41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33534459 |
42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32215907 |
43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32119887 |
44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31564070 |
45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31292372 |
46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29689531 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22552087 |
48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.21443225 |
49 | ABC transporters_Homo sapiens_hsa02010 | 1.19433009 |
50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12759918 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12689254 |
52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08081317 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02354471 |
54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02286780 |
55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00456349 |
56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92966654 |
57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.91324238 |
58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90679578 |
59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89433845 |
60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89059747 |
61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85456411 |
62 | Lysine degradation_Homo sapiens_hsa00310 | 0.83264530 |
63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81224526 |
64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80800105 |
65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80294347 |
66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79525028 |
67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79132963 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76493404 |
69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76384230 |
70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74539282 |
71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74166730 |
72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71366768 |
73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71017104 |
74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.70419836 |
75 | DNA replication_Homo sapiens_hsa03030 | 0.70071049 |
76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66480987 |
77 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.66049925 |
78 | Base excision repair_Homo sapiens_hsa03410 | 0.65726931 |
79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65613690 |
80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61150934 |
81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61118034 |
82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60840691 |
83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57961962 |
84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57085729 |
85 | Prostate cancer_Homo sapiens_hsa05215 | 0.54405692 |
86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53953433 |
87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52052129 |
88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51196255 |
89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50771245 |
90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48746986 |
91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48232194 |
92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47732651 |
93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46957564 |
94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46181541 |
95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43571671 |
96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42663835 |
97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41117971 |
98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40217525 |
99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38136576 |
100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36766910 |
101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36605946 |
102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36061597 |
103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33916692 |
104 | Prion diseases_Homo sapiens_hsa05020 | 0.30462087 |
105 | Insulin resistance_Homo sapiens_hsa04931 | 0.28424623 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22690476 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14859865 |
108 | Bladder cancer_Homo sapiens_hsa05219 | 0.14594188 |
109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14327631 |
110 | Mineral absorption_Homo sapiens_hsa04978 | 0.11633890 |
111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11098364 |
112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10546535 |
113 | Protein export_Homo sapiens_hsa03060 | 0.10201055 |
114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.05827893 |
115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02301352 |
116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01238849 |
117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1241119 |
118 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1162441 |
119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1146777 |
120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1048978 |
121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1044362 |
122 | Tight junction_Homo sapiens_hsa04530 | -0.0725106 |
123 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0528752 |
124 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0505511 |
125 | Adherens junction_Homo sapiens_hsa04520 | -0.0497962 |
126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0441976 |
127 | Thyroid cancer_Homo sapiens_hsa05216 | -0.0294406 |
128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0255268 |
129 | Hepatitis C_Homo sapiens_hsa05160 | -0.0098105 |